Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Avantor
(NYSE:AVTR)
Intraday
$24.20
-0.10
[-0.41%]
After-Hours
$24.20
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$24.20
-0.10
[-0.41%]
At close: Apr 19
$24.20
0
[0.00%]
After Hours: 4:24PM EDT
Get Report
Watch
Q1 2024 Earnings in 7 days from now on Fri Apr 26th, before the market open
Conference call scheduled in 7 days at 8:00 AM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Avantor Stock (NYSE:AVTR)
Avantor Stock (NYSE: AVTR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 18, 2024
Deutsche Bank Maintains Hold on Avantor, Raises Price Target to $25
Benzinga Newsdesk
-
1 day ago
Wednesday, April 10, 2024
Barclays Maintains Overweight on Avantor, Raises Price Target to $30
Benzinga Newsdesk
-
Apr 10, 2024, 3:35PM
Thursday, April 04, 2024
9 Analysts Assess Avantor: What You Need To Know
Benzinga Insights
-
Apr 4, 2024, 2:00PM
Evercore ISI Group Maintains Outperform on Avantor, Raises Price Target to $28
Benzinga Newsdesk
-
Apr 4, 2024, 12:25PM
Wednesday, March 13, 2024
Top 7 Biotech Stock Winners As Weight Loss Drug Battle Escalates: Goldman Sachs Names Best Picks
Piero Cingari
-
Mar 13, 2024, 12:35PM
Thursday, February 15, 2024
RBC Capital Maintains Outperform on Avantor, Raises Price Target to $29
Benzinga Newsdesk
-
Feb 15, 2024, 10:05AM
Where Avantor Stands With Analysts
Benzinga Insights
-
Feb 15, 2024, 9:00AM
Wednesday, February 14, 2024
Avantor shares are trading higher after the company reported better-than-expected Q4 results.
Benzinga Newsdesk
-
Feb 14, 2024, 10:09AM
Avantor Reports Q4 2023 Operating Cash Flow Of $251.6M, With Free Cash Flow Of $201M
Benzinga Newsdesk
-
Feb 14, 2024, 6:03AM
Avantor Q4 Adjusted EPS $0.25 Beats $0.22 Estimate, Sales $1.72B Beat $1.70B Estimate
Benzinga Newsdesk
-
Feb 14, 2024, 6:01AM
Earnings Scheduled For February 14, 2024
Benzinga Insights
-
Feb 14, 2024, 4:48AM
Monday, February 12, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Feb 12, 2024, 12:35PM
Friday, January 26, 2024
Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Jan 26, 2024, 10:30AM
Avantor shares are trading higher after Raymond James maintained an Outperform rating on the stock and raised its price target from $22.5 to $26.
Benzinga Newsdesk
-
Jan 26, 2024, 8:37AM
Evaluating Avantor: Insights From 10 Financial Analysts
Benzinga Insights
-
Jan 26, 2024, 8:01AM
Raymond James Maintains Outperform on Avantor, Raises Price Target to $26
Benzinga Newsdesk
-
Jan 26, 2024, 7:35AM
Tuesday, January 09, 2024
RBC Capital Reiterates Outperform on Avantor, Maintains $28 Price Target
Benzinga Newsdesk
-
Jan 9, 2024, 8:30AM
Thursday, January 04, 2024
Navigating 8 Analyst Ratings For Avantor
Benzinga Insights
-
Jan 4, 2024, 12:00PM
Evercore ISI Group Upgrades Avantor to Outperform, Raises Price Target to $26
Benzinga Newsdesk
-
Jan 4, 2024, 9:20AM
Wednesday, December 13, 2023
Wolfe Research Initiates Coverage On Avantor with Peer Perform Rating
Benzinga Newsdesk
-
Dec 13, 2023, 5:16AM
Tuesday, December 12, 2023
Deutsche Bank Maintains Hold on Avantor, Raises Price Target to $22
Benzinga Newsdesk
-
Dec 12, 2023, 10:25AM
Monday, December 11, 2023
Barclays Maintains Overweight Rating for Avantor: Here's What You Need To Know
Benzinga Insights
-
Dec 11, 2023, 12:00PM
Barclays Maintains Overweight on Avantor, Raises Price Target to $24
Benzinga Newsdesk
-
Dec 11, 2023, 8:44AM
TD Cowen Upgrades Avantor to Outperform, Announces $28 Price Target
Benzinga Newsdesk
-
Dec 11, 2023, 7:59AM
Friday, December 08, 2023
Avantor shares are trading higher following the company's investor day, where it announced a new strategic operating model, a multi-year cost optimization initiative and reaffirmed fiscal year 2023 guidance.
Benzinga Newsdesk
-
Dec 8, 2023, 10:40AM
Biotechnology Company Avantor Aligns Business Segments, Eyes Cost Savings
Lekha Gupta
-
Dec 8, 2023, 5:48AM
Thursday, December 07, 2023
Avantor To Transition From Three Geographic Segments To Two Complementary Business Segments
Benzinga Newsdesk
-
Dec 7, 2023, 4:47PM
Avantor Reaffirms Fiscal Year 2023 Guidance; Launches Cost Optimization Initiative To Deliver $300M In Run Rate Savings By End Of 2026
Benzinga Newsdesk
-
Dec 7, 2023, 4:47PM
What 6 Analyst Ratings Have To Say About Avantor
Benzinga Insights
-
Dec 7, 2023, 10:00AM
Goldman Sachs Maintains Buy on Avantor, Raises Price Target to $26
Benzinga Newsdesk
-
Dec 7, 2023, 9:28AM
Monday, October 30, 2023
Morgan Stanley Maintains Overweight on Avantor, Lowers Price Target to $22
Benzinga Newsdesk
-
Oct 30, 2023, 10:18AM
Barclays Maintains Overweight on Avantor, Lowers Price Target to $21
Benzinga Newsdesk
-
Oct 30, 2023, 9:20AM
Raymond James Maintains Outperform on Avantor, Lowers Price Target to $22.5
Benzinga Newsdesk
-
Oct 30, 2023, 4:46AM
Friday, October 27, 2023
Avantor shares are trading lower. The company reported Q3 financial results.
Benzinga Newsdesk
-
Oct 27, 2023, 11:06AM
Avantor Q3 EPS $0.25, Inline, Sales $1.72B Beat $1.70B Estimate
Benzinga Newsdesk
-
Oct 27, 2023, 6:08AM
Earnings Scheduled For October 27, 2023
Benzinga Insights
-
Oct 27, 2023, 4:33AM
Thursday, October 26, 2023
Avantor's Earnings Outlook
Benzinga Insights
-
Oct 26, 2023, 12:01PM
Thursday, October 12, 2023
Avantor Unusual Options Activity
Benzinga Insights
-
Oct 12, 2023, 4:46PM
Friday, September 29, 2023
Avantor Option Alert: Jan 19 $22.5 Calls Sweep (32) near the Ask: 2427 @ $1.3 vs 766 OI; Earnings 10/27 Before Open Ref=$21.29
Charles Gross
-
Sep 29, 2023, 10:05AM
Check Out What Whales Are Doing With AVTR
Benzinga Insights
-
Sep 29, 2023, 10:01AM
Barclays Maintains Overweight on Avantor, Raises Price Target to $25
Benzinga Newsdesk
-
Sep 29, 2023, 6:00AM
Thursday, September 28, 2023
Expert Ratings for Avantor
Benzinga Insights
-
Sep 28, 2023, 11:00AM
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Benzinga Insights
-
Sep 28, 2023, 11:00AM
Bernstein Initiates Coverage On Avantor with Market Perform Rating, Announces Price Target of $22
Benzinga Newsdesk
-
Sep 28, 2023, 6:34AM
Friday, September 08, 2023
SVP & Chief Accounting Officer of Avantor Sold $156K In Stock
Benzinga Insights
-
Sep 8, 2023, 11:04AM
Thursday, September 07, 2023
Avantor Option Alert: Nov 17 $22.5 Calls at the Ask: 432 @ $0.75 vs 12418 OI; Earnings 10/27 Before Open [est] Ref=$20.68'; Avantor Option Alert: Nov 17 $22.5 Calls Sweep (24) near the Ask: 814 @ $0.75 vs 12418 OI; Earnings 10/
Charles Gross
-
Sep 7, 2023, 11:46AM
Avantor Penned An Agreement With Tobin Scientific To Support Biopharma Customers Looking To Relocate Their Labs, Research Facilities, And Samples
Benzinga Newsdesk
-
Sep 7, 2023, 7:11AM
Tuesday, August 29, 2023
Avantor EVP Sold $536K In Company Stock
Benzinga Insights
-
Aug 29, 2023, 11:02AM
Thursday, August 10, 2023
EVP at Avantor Acquires Company Stock Options Worth 295,559 Shares
Benzinga Insights
-
Aug 10, 2023, 11:01AM
Tuesday, August 01, 2023
Analyst Expectations for Avantor's Future
Benzinga Insights
-
Aug 1, 2023, 12:00PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch